Medindia
Medindia LOGIN REGISTER
Advertisement

Inclinix Announces New Patent for Expert System Platform

Tuesday, March 11, 2008 General News
Advertisement
WILMINGTON, N.C., March 10 Inclinix, Inc., an enrollmentcontract research organization (CRO) and provider of clinical trialrecruitment solutions, announced today that it has received a patent for itsExpert System Platform (ESP). ESP is a software system that guides interviewquestions during patient qualification for clinical trials of new drugs ormedical devices.
Advertisement

Inclinix advertises to recruit patients into clinical trials. Respondentsto Inclinix advertising answer questions on a Web site or when interacting viaphone with Inclinix TeleMEDICINE(TM) Contact Center representatives. Thequestions posed to respondents determine if the respondents fit the inclusionand exclusion criteria from the trial sponsor, usually a pharmaceuticalcompany.
Advertisement

ESP dynamically organizes questions for the interview, changing questionorder or removing questions depending on the answers. ESP is particularlyhelpful for simultaneous trials. The system can automatically switch theprospective trial candidate to questions for a sponsor's second, third orfourth trial if he or she does not qualify for the first one.

ESP inventor and Inclinix Chief Operating Officer Chris Sleat said: "Theway that the system is built turns the previous interviewing automationprocesses and logic on its head. With ESP, the data defines the screeninglogic, so users do not have to think about the structure or dependencies ofthe interview. ESP is vastly superior to a static interview script."

ESP includes the ability to leverage data from prior volunteers who haveelected to be included in a database for consideration in future trials. EPSworks well in combination with internal reporting systems.

ESP also supports novel medical questionnaires, and the platform has beenused in homeland security applications. The design supports interviewingpatients in terrorist incidents to see if they are victims of weapons of massdestruction. The ESP system initiates questions about multiple possibleweapons exposure and then narrows the inquiry based on answers.

The patent number for the Expert System Platform is 7330842.

About Inclinix

Founded in 1999, Inclinix, Inc., is the industry's Enrollment CRO.Inclinix's IQM(TM) Intelligent Enrollment process uses technology to amplifytraditional services and is proven to accelerate trials for pharmaceutical,biotechnology and medical-device organizations. In addition to its clinicalresearch-related offerings, Inclinix provides strategic medical marketingcommunications and adherence services to the healthcare industry. For moreinformation on Inclinix, visit www.inclinix.com

SOURCE Inclinix, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close